Takaaki Fujii

5.7k total citations
167 papers, 2.5k citations indexed

About

Takaaki Fujii is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Takaaki Fujii has authored 167 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 51 papers in Surgery and 47 papers in Cancer Research. Recurrent topics in Takaaki Fujii's work include Breast Cancer Treatment Studies (26 papers), Cancer Cells and Metastasis (13 papers) and Colorectal Cancer Surgical Treatments (11 papers). Takaaki Fujii is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Cancer Cells and Metastasis (13 papers) and Colorectal Cancer Surgical Treatments (11 papers). Takaaki Fujii collaborates with scholars based in Japan, United Kingdom and United States. Takaaki Fujii's co-authors include Hiroyuki Kuwano, Reina Yajima, Soichi Tsutsumi, Takayuki Asao, Sasagu Kurozumi, Satoru Yamaguchi, Ken Shirabe, Hiroki Morita, Jun Horiguchi and Yuichi Tabe and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Takaaki Fujii

162 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takaaki Fujii Japan 28 859 774 691 558 535 167 2.5k
Hiromi Yasuda Japan 28 1.1k 1.2× 677 0.9× 484 0.7× 493 0.9× 611 1.1× 108 2.2k
Masanori Yasuda Japan 26 588 0.7× 583 0.8× 701 1.0× 425 0.8× 518 1.0× 258 2.7k
Ann Hoeben Netherlands 21 781 0.9× 518 0.7× 1.1k 1.6× 455 0.8× 599 1.1× 72 2.9k
Luka Brčić Austria 31 606 0.7× 655 0.8× 563 0.8× 313 0.6× 882 1.6× 143 2.5k
Markus Steinbauer Germany 24 804 0.9× 967 1.2× 1.1k 1.6× 325 0.6× 718 1.3× 86 3.3k
Yu‐Wen Tien Taiwan 31 1.4k 1.6× 1.2k 1.5× 582 0.8× 417 0.7× 503 0.9× 144 2.9k
Soichi Tsutsumi Japan 25 754 0.9× 668 0.9× 1.0k 1.5× 455 0.8× 279 0.5× 105 2.4k
Sofia Tseleni‐Balafouta Greece 29 741 0.9× 1.0k 1.3× 897 1.3× 453 0.8× 192 0.4× 91 3.4k
Kazuyuki Ishida Japan 33 1.1k 1.2× 1.1k 1.4× 799 1.2× 389 0.7× 795 1.5× 190 3.4k
Paolo Viacava Italy 32 800 0.9× 718 0.9× 1.1k 1.5× 431 0.8× 386 0.7× 117 3.3k

Countries citing papers authored by Takaaki Fujii

Since Specialization
Citations

This map shows the geographic impact of Takaaki Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takaaki Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takaaki Fujii more than expected).

Fields of papers citing papers by Takaaki Fujii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takaaki Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takaaki Fujii. The network helps show where Takaaki Fujii may publish in the future.

Co-authorship network of co-authors of Takaaki Fujii

This figure shows the co-authorship network connecting the top 25 collaborators of Takaaki Fujii. A scholar is included among the top collaborators of Takaaki Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takaaki Fujii. Takaaki Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurozumi, Sasagu, Naohiko Seki, Chikako Honda, et al.. (2023). Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer. International Journal of Molecular Sciences. 25(1). 35–35. 3 indexed citations
2.
Kurozumi, Sasagu, Kyoichi Kaira, Hiroshi Matsumoto, et al.. (2022). Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer. Scientific Reports. 12(1). 2742–2742. 29 indexed citations
3.
Fujii, Takaaki, et al.. (2021). Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer. Anticancer Research. 41(8). 3899–3904. 5 indexed citations
4.
Fujii, Takaaki, Yuko Nakazawa, Reina Yajima, et al.. (2021). Oncological safety of immediate breast reconstruction with skin- or nipple-sparing mastectomy: the value of tumor-to-dermis distance measured by preoperative ultrasonography. World Journal of Surgical Oncology. 19(1). 72–72. 10 indexed citations
5.
Fujii, Takaaki, et al.. (2020). Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer. In Vivo. 34(4). 2033–2036. 35 indexed citations
6.
Fujii, Takaaki, Chikako Honda, Yuko Nakazawa, et al.. (2020). Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients. Breast Cancer. 28(2). 329–334. 3 indexed citations
7.
8.
9.
Fujii, Takaaki, et al.. (2020). Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer. In Vivo. 34(2). 917–921. 9 indexed citations
10.
Fujii, Takaaki, et al.. (2020). Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer. BMC Cancer. 20(1). 1068–1068. 2 indexed citations
11.
Fujii, Takaaki, Sasagu Kurozumi, Ayaka Katayama, et al.. (2020). FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer. Breast Cancer Research and Treatment. 181(2). 331–338. 28 indexed citations
12.
Kurozumi, Sasagu, Kenichi Inoue, Hiroshi Matsumoto, et al.. (2019). Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer. Scientific Reports. 9(1). 1583–1583. 40 indexed citations
13.
Kurozumi, Sasagu, Yuri Yamaguchi, Hiroshi Matsumoto, et al.. (2019). Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy. PLoS ONE. 14(5). e0217279–e0217279. 5 indexed citations
14.
Kurozumi, Sasagu, Kenichi Inoue, Hiroshi Matsumoto, et al.. (2019). Clinicopathological values of PD-L1 expression in HER2-positive breast cancer. Scientific Reports. 9(1). 16662–16662. 39 indexed citations
15.
16.
Kurozumi, Sasagu, Yuri Yamaguchi, Hiroshi Matsumoto, et al.. (2018). Comparing protein and mRNA expressions of the human epidermal growth factor receptor family in estrogen receptor-positive breast cancer. Medical Molecular Morphology. 52(2). 90–98. 5 indexed citations
17.
Fujii, Takaaki, et al.. (2010). Implication of Extracapsular Invasion of Sentinel Lymph Nodes in Breast Cancer: Prediction of Nonsentinel Lymph Node Metastasis. World Journal of Surgery. 34(3). 544–548. 31 indexed citations
18.
Fujii, Takaaki, Toshihiro Nakabayashi, Shinji Hashimoto, & Hiroyuki Kuwano. (2009). Successful perioperative management of patients with Parkinson’s disease following gastrointestinal surgery: Report of three cases. Surgery Today. 39(9). 807–810. 6 indexed citations
19.
Katagishi, Tatsuo, Takao Kojima, Takaaki Fujii, et al.. (1994). Evaluation of endoscopic variceal ligation (evl) for esophagogastric varices. Acta gastro-enterologica belgica. 36(10). 1964–1968. 3 indexed citations
20.
Fujii, Takaaki, et al.. (1993). [Appearance of hallucinations and one-and-a-half syndrome after resection of a cavernous angioma located in the fourth ventricle floor].. PubMed. 21(2). 157–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromi Yasuda Breakdown of academic impact, for papers by Masanori Yasuda Breakdown of academic impact, for papers by Ann Hoeben Breakdown of academic impact, for papers by Luka Brčić Breakdown of academic impact, for papers by Markus Steinbauer Breakdown of academic impact, for papers by Yu‐Wen Tien Breakdown of academic impact, for papers by Soichi Tsutsumi Breakdown of academic impact, for papers by Sofia Tseleni‐Balafouta Breakdown of academic impact, for papers by Kazuyuki Ishida Breakdown of academic impact, for papers by Paolo Viacava
Rankless by CCL
2026